New award for emtricitabine 200MG/tenofovir disoproxil fumarate 300MG tablets with avkare, LLC. Base year ordering period is october 6, 2025 to october 5, 2026 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79725D0046
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 54% complete
IDV ceiling
$9,977,967.85
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Avkare LLC on October 6, 2025, for Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg tablets with a ceiling of $9,977,967.85. The base ordering period runs from October 6, 2025, through October 5, 2026, with four one-year options extending to October 5, 2030. This is an unrestricted, full-and-open procurement with no set-aside applied.

Place of performance is Pulaski, Tennessee. The contract serves multiple federal healthcare beneficiaries: the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution through VA and Department of Defense Pharmaceutical Prime Vendor Programs. The estimated annual requirement is 91,583 bottles of 30-count tablets. Packaging specifications require 120cc volume bottles with safety caps and distinct labeling without overlays. The product carries NAICS code 325412 for Pharmaceutical Preparation Manufacturing.

The originating solicitation (36E79725R0035) was posted as a pre-solicitation notice on April 10, 2025, with a due date of May 13, 2025. The VA sought a responsible offeror capable of providing uninterrupted supply of the specified pharmaceutical product under commercial-item format (FAR Part 12).

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · Implementing EO 14398 DEI discrimination $0
Exercise an Option P00002 · Exercise option year 1, effective 10/06/2026 - 10/05/2027,contract 36E79725D0046 for emtricitabine 200MG/tenofovir disoproxil fumarate 300MG tablets. $0
Add Subcontract Plan P00001 · Incorporation of 2026 small business subcontracting plan into contract 36E79725D0046 - emtricitabine/tenofovir. $0
Original award $0

Quick answers

Who was awarded contract 36E79725D0046?

36E79725D0046 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on October 6, 2025.

How much is contract 36E79725D0046 worth?

36E79725D0046's own ceiling is $9,977,968.

Who can order from contract 36E79725D0046?

36E79725D0046 is a single award indefinite delivery contract.

Was contract 36E79725D0046 competed?

The extent of competition for 36E79725D0046 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV